Tafenoquine approved by US FDA for radical cure of vivax malaria

On 20 July 2018, GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) announced that The United States Food and Drug … Continue reading Tafenoquine approved by US FDA for radical cure of vivax malaria